FDA ApprovedUnited States
A New Copper Treatment for Children with Menkes Disease
Zycubo (copper histidinate) — subcutaneous copper replacement for Menkes disease in pediatric patients
FDA approval on 12 January 2026 for Zycubo (copper histidinate) for injection — a subcutaneous copper replacement — for Menkes disease in pediatric patients.
This is for families of children with Menkes disease who may be candidates for labelled US Zycubo subcutaneous copper replacement — especially when treatment…